The IFA Open Access Book has already been downloaded 600.000+ times

This open access book, published by Springer under the Open Access CC BY 4.0 Licence in collaboration with the International Fluid Academy (IFA, www.fluidacademy.org), explores rationalized intravenous fluid therapy for critically ill patients. Despite being commonly prescribed in inpatient settings, intravenous fluids are often administered without evidence-based guidelines, neglecting essential considerations such as the fact they are drugs, that need proper dosing, duration, indications, contraindications, side effects, and de-escalation. This book fills this knowledge gap.

Each chapter starts with a clinical vignette and a related question, followed by a concise summary abstract, key learning points, main text, and a conclusion that addresses the clinical question and provides relevant take-home messages. Additionally, every chapter includes an IFA commentary referencing the latest literature and evidence. The book begins with an introductory chapter that provides definitions and terminology, followed by four sections.

The first section covers the fundamentals of intravenous fluid therapy, including fluid compartments in sick patients, fluid bolus dynamics, heart-lung interactions, fluid challenge, fluid responsiveness, arterial blood gas analysis based on traditional and Stewart concepts, and electrolyte physiology relevant to clinical issues. The second section discusses commercially available intravenous fluids, while the third section focuses on fluid therapy in specific clinical situations. The final section introduces the concepts of fluid stewardship and appropriate fluid prescription.

Happy Reading

Evidence based personalized fluid decisions

More than 80% of hospitalized patients receive IV fluids.¹ However, 1 in 5 patients may suffer complications or morbidity due to inappropriate administration of IV fluids.²

Until IV fluid therapy is correctly managed, optimal outcomes may not be achieved. The amount and type of IV fluid must be considered before administration.^2,3Clinicians need real-time, precise physiologic data to make well-informed choices about whether fluid is the right intervention and, if so, what type and how much is appropriate to support the patient's pathway to recovery.

Baxter offers a range of fluid management products designed to help clinicians improve outcomes by making evidence-based, personalized fluid decisions. To find out more visit our new website: https://emeamedicationdelivery.baxter.com/contact

References:

1.Yucha CB, Hastings-Tolsma M, Szevereny NM. Differences among intravenous extravasations using four common solutions. J Intraven Nurs. 1993;16(5):277-281.

2. National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. NICE Clinical guideline 174, 2013.

3. Nursing Times. NICE guidance on giving intravenous fluids. January 2014.

EMA-MD6-230024 v1.0 11/2023

Posted in IFAD 2023 Written by Administrator on Wednesday, 22 November 2023. Hits 29593